Advertisement

Topics

Inflazome Company Profile

17:30 EST 11th December 2018 | BioPortfolio

Utilizing the scientific expertise of our founders and advisors, Inflazome is leading the way in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the NLRP3 inflammasome, which is now understood to drive many chronic and acute inflammatory conditions from Parkinson’s and Alzheimer’s to Cardiovascular Diseases.


News Articles [17 Associated News Articles listed on BioPortfolio]

Funding round brings in $45.7M for Inflazome

A round of Series B funding pulled in $45.7 million for Inflazome.  -More- 

Fresh Funding Pushes Inflazome Into Clinic With Inflammation Inhibitors

With $46m funding fresh in its pocket, Dublin biotech Inflazome tells Scrip how it will advance its clinical candidates in multiple indications.   

Deals this week: Roivant Sciences, Inflazome, Santhera

Roivant Sciences will use biologic drug candidate SAL200 are entering a global licensing agreement worth $667.5m with iNtRON Biotechnology. iNtRON...Read More... The post Deals this week: Roivant Scie...

Inflazome closes €40mm Series B financing

Inflazome Ltd. (developing small-molecule therapies that block harmful inflammation) raised €40mm ($46mm) in its Series B financing led by Forbion, which was joined by other new backer Longitude Cap...

Forbion leads €40m financing in Inflazome Ltd

Management tracks: Inflazome, Clementia

Inflazome's inflammasome inhibitor could treat Parkinson's

Inflazome to bring inflammasome inhibitors to clinic with €40M series B

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Inflazome

Utilizing the scientific expertise of our founders and advisors, Inflazome is leading the way in developing orally available drugs to address clinical unmet needs in inflammatory ...

More Information about "Inflazome" on BioPortfolio

We have published hundreds of Inflazome news stories on BioPortfolio along with dozens of Inflazome Clinical Trials and PubMed Articles about Inflazome for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inflazome Companies in our database. You can also find out about relevant Inflazome Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record